This expert-led webinar from a PTC Therapeutics-sponsored meeting provides an update on the scientific approaches to the treatment of Duchenne muscular dystrophy (DMD), with specific reference to nonsense readthrough agents
Webinar: Latest scientific updates of nonsense readthrough agents
MED-ALL-CORP-2200029 | December 2022
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.